These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24062235)

  • 1. Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; So TM; Hsueh PR;
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):55-9. PubMed ID: 24062235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Community-Onset Pneumonia Caused by Levofloxacin-Nonsusceptible Streptococcus pneumoniae.
    Seok H; Kang CI; Huh K; Cho SY; Ha YE; Chung DR; Peck KR
    Microb Drug Resist; 2018 Nov; 24(9):1412-1416. PubMed ID: 29565225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-nonsusceptible Streptococcus pneumoniae isolates from a medical center in the pneumococcal conjugate vaccine era.
    Chen HH; Li HC; Su LH; Chiu CH
    J Microbiol Immunol Infect; 2017 Dec; 50(6):839-845. PubMed ID: 27342636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan.
    Hsieh YC; Chang LY; Huang YC; Lin HC; Huang LM; Hsueh PR
    Clin Microbiol Infect; 2010 Jul; 16(7):973-8. PubMed ID: 19778298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae.
    Isea-Peña MC; Sanz-Moreno JC; Esteban J; Fernández-Roblas R; Fernández-Guerrero ML
    Infection; 2013 Oct; 41(5):935-9. PubMed ID: 23709294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
    Baek JY; Kang CI; Kim SH; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):287-290. PubMed ID: 29540263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing prevalence of levofloxacin-resistant Streptococcus pneumoniae in Hong Kong, 2001 to 2007.
    Ho PL; Cheng VC; Chow KH
    J Antimicrob Chemother; 2009 Apr; 63(4):836-8. PubMed ID: 19218570
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
    Wu YH; Chen PL; Hung YP; Ko WC
    J Microbiol Immunol Infect; 2014 Jun; 47(3):197-203. PubMed ID: 23063776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients with respiratory tract infections in Thailand.
    Srifuengfung S; Tribuddharat C; Champreeda P; Daniels J; Chokephaibulkit K; Wongwan N; Polwichai P
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):461-6. PubMed ID: 18564685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema].
    Carlavilla AB; López-Medrano F; Chaves F; Villena V; Echave-Sustaeta J; Aguado JM
    Enferm Infecc Microbiol Clin; 2005 May; 23(5):270-3. PubMed ID: 15899177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial.
    Fujita J; Niki Y; Kadota J; Yanagihara K; Kaku M; Watanabe A; Aoki N; Hori S; Tanigawara Y; Cash HL; Kohno S
    J Infect Chemother; 2013 Jun; 19(3):472-9. PubMed ID: 23179958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage.
    Pletz MW; van der Linden M; von Baum H; Duesberg CB; Klugman KP; Welte T;
    Int J Med Microbiol; 2011 Jan; 301(1):53-7. PubMed ID: 20692869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of invasive infections in children caused by highly penicillin-resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains.
    Gómez-Barreto D; Calderón-Jaimes E; Rodríguez RS; de los Monteros LE
    Arch Med Res; 2000; 31(6):592-8. PubMed ID: 11257327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 17. Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?
    Bauer T; Ewig S; Marcos MA; Schultze-Werninghaus G; Torres A
    Med Clin North Am; 2001 Nov; 85(6):1367-79. PubMed ID: 11680107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
    Jones RN; Jacobs MR; Sader HS
    Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
    Lee S; Kim SH; Park M; Bae S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):227-31. PubMed ID: 23623384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin-resistant pneumococci-implications for management of community-acquired pneumonia and meningitis.
    Ziglam HM; Finch RG
    Int J Infect Dis; 2002 Mar; 6 Suppl 1():S14-20. PubMed ID: 12044285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.